| Glycine cleavage H-protein | |||||||
|---|---|---|---|---|---|---|---|
refined structures at 2 angstroms and 2.2 angstroms of the two forms of the h-protein, a lipoamide-containing protein of the glycine decarboxylase | |||||||
| Identifiers | |||||||
| Symbol | GCV_H | ||||||
| Pfam | PF01597 | ||||||
| Pfam clan | CL0105 | ||||||
| InterPro | IPR002930 | ||||||
| SCOP2 | 1htp /SCOPe /SUPFAM | ||||||
| |||||||
| Glycine cleavage T-protein, Aminomethyltransferase folate-binding domain | |||||||
|---|---|---|---|---|---|---|---|
crystal structure of a component of glycine cleavage system: t-protein from pyrococcus horikoshii ot3 at 1.5 a resolution | |||||||
| Identifiers | |||||||
| Symbol | GCV_T | ||||||
| Pfam | PF01571 | ||||||
| Pfam clan | CL0289 | ||||||
| InterPro | IPR006222 | ||||||
| SCOP2 | 1pj5 /SCOPe /SUPFAM | ||||||
| |||||||
| Glycine cleavage T-protein C-terminal barrel domain | |||||||
|---|---|---|---|---|---|---|---|
crystal structure of t-protein of the glycine cleavage system | |||||||
| Identifiers | |||||||
| Symbol | GCV_T_C | ||||||
| Pfam | PF08669 | ||||||
| InterPro | IPR013977 | ||||||
| SCOP2 | 1pj5 /SCOPe /SUPFAM | ||||||
| |||||||
Theglycine cleavage system (GCS) is also known as theglycine decarboxylase complex orGDC. The system is a series of enzymes that are triggered in response to high concentrations of the amino acidglycine.[1] The same set of enzymes is sometimes referred to as glycine synthase when it runs in the reverse direction to form glycine.[2] The glycine cleavage system is composed of four proteins: the T-protein, P-protein, L-protein, and H-protein. They do not form a stable complex,[3] so it is more appropriate to call it a "system" instead of a "complex". The H-protein is responsible for interacting with the three other proteins and acts as a shuttle for some of the intermediate products in glycine decarboxylation.[2] In both animals and plants, the glycine cleavage system is loosely attached to the inner membrane of the mitochondria. Mutations in this enzymatic system are linked withglycine encephalopathy.[2]
| Name | EC number | Function |
|---|---|---|
| P-protein (GLDC) | EC1.4.4.2 | glycine dehydrogenase (decarboxylating) or justglycine dehydrogenase (pyridoxal phosphate) |
| T-protein (GCST orAMT) | EC2.1.2.10 | aminomethyltransferase |
| H-protein (GCSH) | is modified withlipoic acid and interacts with all other components in a cycle of reductive methylamination (catalysed by the P-protein), methylamine transfer (catalysed by the T-protein) and electron transfer (catalysed by the L-protein).[3] | |
| L-protein (GCSL orDLD) | EC1.8.1.4 | known by many names, but most commonlydihydrolipoyl dehydrogenase |

In plants, animals and bacteria the glycine cleavage system catalyzes the following reversible reaction:
In the enzymatic reaction, H-protein activates the P-protein, which catalyzes thedecarboxylation of glycine and attaches the intermediate molecule to the H-protein to be shuttled to the T-protein.[4][5] The H-protein forms a complex with the T-protein that usestetrahydrofolate and yieldsammonia and5,10-methylenetetrahydrofolate. After interaction with the T-protein, the H-protein is left with two fully reducedthiol groups in thelipoate group.[6] The glycine protein system is regenerated when the H-protein is oxidized to regenerate the disulfide bond in the active site by interaction with the L-protein, which reduces NAD+ to NADH and H+.
When coupled toserine hydroxymethyltransferase, the glycine cleavage system overall reaction becomes:
In humans and most vertebrates, the glycine cleavage system is part of the most prominent glycine and serine catabolism pathway. This is due in large part to the formation5,10-methylenetetrahydrofolate, which is one of the few C1 donors in biosynthesis.[2] In this case the methyl group derived from the catabolism of glycine can be transferred to other key molecules such aspurines andmethionine.

This reaction, and by extension the glycine cleavage system, is required forphotorespiration in C3 plants. The glycine cleavage system takes glycine, which is created from an unwanted byproduct of theCalvin cycle, and converts it toserine which can reenter the cycle. The ammonia generated by the glycine cleavage system, is assimilated by theGlutamine synthetase-Glutamine oxoglutarate aminotransferase cycle but costs the cell oneATP and oneNADPH. The upside is that one CO2 is produced for every two O2 that are mistakenly taken up by the cell, generating some value in an otherwise energy depleting cycle. Together the proteins involved in these reactions comprise about half the proteins inmitochondria fromspinach andpealeaves.[3] The glycine cleavage system is constantly present in the leaves of plants, but in small amounts until they are exposed to light. During peak photosynthesis, the concentration of the glycine cleavage system increases ten-fold.[7]
In the anaerobic bacteria,Clostridium acidiurici, the glycine cleavage system runs mostly in the direction of glycine synthesis. While glycine synthesis through the cleavage system is possible due to the reversibility of the overall reaction, it is not readily seen in animals.[8][9]
Glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH), is a primary disorder of the glycine cleavage system, resulting from lowered function of the glycine cleavage system causing increased levels of glycine in body fluids. The disease was first clinically linked to the glycine cleavage system in 1969.[10] Early studies showed high levels of glycine in blood, urine and cerebrospinal fluid. Initial research usingcarbon labeling showed decreased levels of CO2 and serine production in the liver, pointing directly to deficiencies glycine cleavage reaction.[11] Further research has shown that deletions and mutations in the 5' region of the P-protein are the major genetic causes of nonketotic hyperglycinemia. .[12] In more rare cases, a missense mutation in the genetic code of the T-protein, causing thehistidine in position 42 to be mutated toarginine, was also found to result in nonketotic hypergycinemia. This specific mutation directly affected the active site of the T-protein, causing lowered efficiency of the glycine cleavage system.[13]